Augmented ustekinumab dosing is needed to achieve clinical response in patients with anti-TNF refractory pediatric Crohn's disease: a retrospective chart review.
暂无分享,去创建一个
Ashish S. Patel | L. Sifuentes-Dominguez | B. Gurram | Gaith Semrin | J. Andersen | Phinga Do | P. Luu | A. Patel | Bhaskar Gurram